EQMS Software: Electronic Quality Management for Regulated Industries

Cloud-native. Regulated-industry built. Part 11 ready.

eQMS Software: A Cloud-Hosted Electronic Quality Management System Built for Pharma, Medical Device, and Regulated Manufacturing

Buyers searching for eQMS software have already made one decision: paper-based or hybrid quality management systems are not adequate for their needs. The question is not whether to operate an electronic quality management system. The question is which electronic QMS platform best fits the regulatory requirements, organisational complexity, and validation obligations of a regulated-industry quality system.

Qualio holds position 1 in this search cluster with a pharma-first eQMS platform. ETQ holds position 2 with an enterprise multi-domain quality and compliance platform. Both are genuine products serving real market segments. eLeaP competes on the ground where neither is strongest: a cloud-native eQMS built for the full regulated-industry spectrum — pharma, medical device, life sciences, and regulated manufacturing — with a native integrated LMS that manages training records and quality records in the same validated system.

This page covers what an eQMS must deliver for regulated industries, the specific requirements for pharmaceutical and medical device eQMS deployments, how cloud deployment satisfies 21 CFR Part 11, and how eLeaP compares to the leading eQMS platforms on the criteria that matter.

eQMS vs. QMS: The Distinction That Drives the Search

The ‘e’ in eQMS is not a marketing prefix. It reflects a material difference in how quality system records are created, stored, reviewed, and retrieved. A paper-based QMS generates paper records: batch records completed by hand, SOPs printed and signed, deviation reports written and filed in binders, and CAPA records managed in spreadsheets. These systems are auditable but inefficient, error-prone at every manual step, and incapable of connecting related records at the system level. A hybrid system combines electronic tools — SharePoint for documents, Excel for CAPA tracking, a standalone LMS for training records — without the integration that makes electronic quality management meaningful.

An electronic quality management system manages every quality record electronically, enforces quality system workflows at the system level, maintains 21 CFR Part 11-compliant audit trails across all record types, and connects quality events to their downstream obligations — training requirements, CAPA actions, change control reviews — through system record relationships rather than manual handoffs. The buyer who has searched for eQMS software is looking for the third option: a system where the quality management processes themselves are electronic and integrated, not just the documents that describe them.

The regulatory consequence of this distinction is visible during FDA inspections. An investigator reviewing a paper or hybrid system examines the paper trail. An investigator reviewing an eQMS examines the system itself: the audit trail of who accessed and modified every record, the workflow history showing how each record moved through its lifecycle stages, and the electronic signature records confirming who approved each document and when. The eQMS produces more complete inspection evidence than a paper system can — if the eQMS was built correctly.

Pharmaceutical eQMS Requirements: ICH Q10 and the Electronic Quality System

ICH Q10 describes the pharmaceutical quality system as having four principal elements: knowledge management, quality risk management, corrective and preventive action, and change management. Section 1.6 of ICH Q10 specifically addresses the use of quality management system software, noting that electronic systems can enhance the effectiveness of the pharmaceutical quality system when they are validated and controlled. The ICH Q10 framework is the architectural blueprint for a pharmaceutical eQMS.

ICH Q10 Section 3.2: Knowledge Management in the eQMS

ICH Q10 Section 3.2 requires that the pharmaceutical quality system support the capture, management, and use of knowledge accumulated through product and process development, technology transfer, commercial manufacturing, and product discontinuation. In an eQMS, knowledge management means that batch production data, deviation history, process validation records, CAPA history, and change control records are accessible as a connected knowledge base rather than dispersed across paper files, binders, and offline spreadsheets. eLeaP’s eQMS connects these record types through system relationships: a deviation links to the batch in which it occurred, the CAPA that addressed its root cause, and the change control that modified the process. The knowledge management requirement of ICH Q10 Section 3.2 is satisfied by the record architecture, not by a separate knowledge management tool.

ICH Q10 Section 3.4: CAPA in the Electronic Quality System

ICH Q10 Section 3.4 requires that a CAPA system address the root cause of nonconformities and verify the effectiveness of corrective actions. The effectiveness verification requirement in ICH Q10 is the element that distinguishes a mature pharmaceutical quality system from one that manages CAPA documentation without managing CAPA outcomes. In eLeaP’s pharmaceutical eQMS, the CAPA workflow requires effectiveness criteria to be defined before corrective action implementation, schedules verification at a defined monitoring interval, and prevents CAPA closure without a completed effectiveness verification sign-off. The electronic enforcement of this requirement — the system prevents closure, it does not simply remind the user — is the advantage of an eQMS over a paper or hybrid CAPA system.

ICH Q10 Section 3.5: Change Management in the eQMS

ICH Q10 Section 3.5 requires that changes to processes, equipment, analytical methods, and quality system elements be controlled through a formal change management process that includes impact assessment, approval, and post-implementation review. The electronic advantage in change management is the connection between the change record and the downstream obligations: the documents requiring revision, the revalidation activities required, and the training assignments that gate implementation. In eLeaP, the change control record is connected to all three through system relationships. The change does not close until each obligation is satisfied.

Batch Records and GMP Documentation in the Pharmaceutical eQMS

21 CFR Part 211.188 requires batch production and control records for each batch of drug product. An electronic batch record system within the eQMS captures each production step with operator identity, server-generated timestamps, and entered values. Out-of-range entries are flagged as deviations and automatically create deviation records in the quality management system without manual routing. The batch release review presents the complete batch record, all in-process test results, and all linked deviation records in a single view for the quality control reviewer. The batch record is retrievable by batch number or lot number in seconds, satisfying the inspection retrieval expectation that paper archives cannot reliably meet.

Medical Device eQMS: DHF Management, DHR Maintenance, and Post-Market Quality Surveillance

Medical device eQMS requirements are governed by 21 CFR Part 820 (now the QMSR, effective February 2026), ISO 13485:2016, and for EU market access, EU MDR 2017/745 and applicable harmonised standards. The medical device eQMS has distinctive requirements that pharmaceutical and general manufacturing eQMS platforms do not address with the same depth: Design History File management, Device History Record maintenance, Medical Device Report evaluation, and post-market surveillance quality management.

Design History File in the Medical Device eQMS

21 CFR Part 820.30(j) requires that a Design History File be established and maintained for each type of device, containing or referencing the records demonstrating that the device was developed in accordance with the approved design plan. An eQMS that manages the DHF as a document folder satisfies the letter of 820.30(j) inadequately — the records exist, but their relationships to each other are not maintained by the system. An eQMS that manages the DHF as a navigable record network satisfies both the letter and the inspection expectation: an auditor can trace from any user need to the design input that addresses it, to the design output that implements it, to the verification test that confirms it, to the validation study that validates the device meets the user need.

eLeaP’s medical device eQMS maintains the DHF as a record network. Design inputs link to their source and to the outputs they drove. Outputs link to verification tests. Verification tests link to the inputs they verify. Design changes link to the DHF records they modify and to the CAPA records that originated them. The traceability matrix is a live view of these system relationships, not a manually maintained document.

Device History Record and Post-Market Quality Surveillance

ISO 13485 Section 7.5.8 requires Device History Records demonstrating that each manufactured unit was produced in accordance with the Device Master Record. Post-market quality surveillance under QMSR and EU MDR requires that feedback from the field — complaints, vigilance reports, post-market clinical follow-up data — feeds back into the quality system as inputs for CAPA, design change decisions, and risk management updates. An eQMS that connects the DHR for each produced unit to the complaint records for that device family, and connects complaint trends to design change initiation, creates the post-market quality surveillance architecture that the QMSR and EU MDR require.

eLeaP’s medical device eQMS links DHR records to the DMR version in effect at the time of production, to equipment qualification records for equipment used, and to training records for operators who performed each production step. Complaint records link to the complaint trend analysis and, where a trend indicates a design-related quality issue, to the design change record initiated in response. The post-market quality surveillance loop — from field complaint to trend analysis to design change to updated DHF — is a connected record chain in the eQMS rather than a manual aggregation exercise.

MDR Evaluation in the Medical Device eQMS

21 CFR Part 803 requires medical device manufacturers to report to the FDA when a device may have caused or contributed to a death or serious injury, or when a device malfunctioned and would be likely to cause or contribute to a death or serious injury if it recurred. The MDR evaluation is a required workflow stage in every complaint that may involve a device malfunction with patient impact. An eQMS that manages complaint handling without a structured MDR evaluation workflow — one that walks through the Part 803 reportability criteria, documents the determination with rationale, and tracks the submission date against the applicable 30-day or 5-day reporting window — is not a medical device eQMS in the regulatory sense.

eLeaP’s medical device eQMS includes the MDR evaluation workflow as a required stage in the complaint record for device malfunction and adverse event complaints. The evaluation fields walk through the Part 803 criteria. The determination and rationale are captured in the record’s permanent history. MDR submission tracking records the submission date against the reporting window and generates escalation notifications for approaching deadlines. MDR amendment records link to the original MDR submission within the complaint record.

Cloud eQMS Deployment: Hosting, Security, and 21 CFR Part 11 Compliance

Cloud deployment of an eQMS raises three questions that regulated-industry buyers consistently ask: where are my records hosted, is the system secure enough for GxP data, and how do cloud-hosted electronic records satisfy 21 CFR Part 11? Each question has a specific answer for eLeaP’s cloud deployment architecture.

Data Hosting and Infrastructure

eLeaP’s eQMS is hosted on enterprise cloud infrastructure with defined specifications for availability, data isolation, geographic redundancy, backup frequency, and disaster recovery capability. The hosting environment specifications are documented in the Installation Qualification report provided to customers as part of the validation support package. Data is hosted in the geographic region selected at implementation, with options appropriate for US-regulated, EU-regulated, and multi-region deployments. Backup procedures run at defined intervals with tested recovery procedures. Infrastructure access is restricted to authorised personnel and is logged in the infrastructure access audit trail, separate from the application-layer audit trail.

Security Architecture for GxP Data

GxP data in eLeaP’s cloud eQMS is protected through encryption at rest and in transit, role-based access controls that restrict data access to authorised users and roles, multi-factor authentication options for user account access, and session timeout controls that terminate inactive sessions after a configurable interval. The security architecture documentation, including penetration testing reports and security control descriptions, is available to customers under NDA as part of the due diligence process. Customers in regulated environments with specific security requirements — SOC 2 Type II compliance, specific data residency requirements, or integration with enterprise identity management systems — are assessed as part of the implementation scoping process.

21 CFR Part 11 Compliance in a Cloud-Hosted eQMS

21 CFR Part 11 does not distinguish between records maintained on-premises and records maintained in cloud-hosted systems. The regulation applies to electronic records subject to FDA regulations, regardless of where those records are physically stored. Cloud-hosted electronic records satisfy Part 11 if the system satisfies Part 11’s technical and procedural requirements: computer-generated time-stamped audit trails that are tamper-evident and user-inaccessible for modification, electronic signatures that are unique to one individual and require two-factor authentication at the time of signing, and system validation demonstrating accuracy and reliability.

In a cloud eQMS, the validation responsibility is shared between the cloud provider and the regulated user in a specific way that differs from on-premises installations. The cloud provider — eLeaP in this case — is responsible for the Installation Qualification of the hosting infrastructure and the Operational Qualification of the application. The regulated user is responsible for the Performance Qualification against their specific configured workflows and for ongoing validation maintenance through the system’s change control process. eLeaP provides the IQ report, OQ test library, Part 11 traceability matrix, and PQ protocol templates as part of the validation support package. The customer executes the PQ and generates the validation summary report.

The audit trail in eLeaP’s cloud eQMS is maintained in a separately secured audit log database hosted in the same infrastructure as the application data. The audit trail is tamper-evident: it is inaccessible for modification by any user,r including system administrators, and the database-layer separation between operational data and audit log data is documented in the system architecture documentation. Cloud hosting does not weaken the audit trail architecture — it strengthens it, because the audit trail infrastructure is maintained by eLeaP with enterprise-grade availability and backup procedures rather than being dependent on the customer’s on-premises IT infrastructure.

eQMS Platform Comparison: Qualio, ETQ, and eLeaP

The leading eQMS platforms for regulated industries are evaluated below against the requirements covered in this page: pharmaceutical eQMS capability, medical device eQMS capability, cloud deployment architecture, training integration, and total cost of ownership for the mid-market regulated buyer.

Qualio eQMS

Qualio is a cloud-native eQMS built primarily for pharma, biotech, and early-stage life sciences companies. Their platform is modern, clean, and fast to implement. Pharmaceutical eQMS capability: strong on GMP document control, CAPA, and training for small-to-mid-size pharma organisations. Medical device eQMS capability: limited to design controls, DHF management, and MDR evaluation workflow to the depth that a dedicated device manufacturer requires. Training integration: training module present, but not a native LMS with automated training matrix management. Cloud deployment: fully cloud-hosted with appropriate security architecture. TCO: competitive for the small pharma and biotech segment.

Qualio is the right fit for an early-stage pharma or biotech company that needs a clean, fast-to-implement cloud eQMS for GMP compliance. It is not the right fit for a medical device manufacturer where DHF management, DHR maintenance, and MDR evaluation are primary requirements, or for a complex regulated manufacturer that needs multi-standard and multi-site configurations.

ETQ eQMS (Hexagon)

ETQ is a broad cloud-hosted quality and compliance platform with genuine depth across quality management, EHS, and environmental compliance. Pharmaceutical eQMS capability: present at a functional level. Medical device eQMS capability: present but not purpose-built for the device-specific requirements that a Notified Body auditor will examine in detail. Training integration: training module present, not a native integrated LMS. Cloud deployment: fully cloud-hosted with enterprise security architecture. TCO: enterprise range, reflecting the platform’s scope breadth.

ETQ is the right fit for a large enterprise organisation that needs quality, EHS, and environmental management in a single cloud platform. For a regulated manufacturer focused specifically on GxP quality management, ETQ’s multi-domain scope adds implementation complexity that exceeds what a dedicated eQMS requires.

eLeaP eQMS

eLeaP is a cloud-native eQMS built from the ground up for regulated-industry quality management across pharmaceuticals, medical devices, life sciences, and regulated manufacturing. Pharmaceutical eQMS capability: ICH Q10-aligned across knowledge management, CAPA, change management, and GMP documentation, including electronic batch records. Medical device eQMS capability: QMSR and ISO 13485-aligned with DHF record network management, DHR-to-DMR traceability, MDR evaluation workflow, and post-market quality surveillance connection. Training integration: the only eQMS platform with a native integrated LMS that manages quality records and training records in the same validated system — automated training assignment on document revision, role-change delta calculation, and CAPA-triggered retraining. Cloud deployment: fully cloud-hosted with IQ/OQ validation support package, Part 11 traceability matrix, and CSA risk classification documentation. TCO: mid-market competitive, below MasterControl and ETQ, with a broader regulatory scope than Qualio.

Where eLeaP is not the right fit: a very small startup needing the simplest possible cloud eQMS for a first regulatory submission will find Qualio faster to implement. A large enterprise organisation needing quality, EHS, and environmental management in one platform will find ETQ’s scope more appropriate. For mid-market regulated manufacturers, pharmaceutical and biotech companies beyond early stage, contract manufacturers managing multi-client quality programs, and medical device manufacturers in active production, eLeaP’s combination of regulated-industry depth, native training integration, and mid-market TCO is the strongest fit.

Evaluating eQMS Software: Five Questions for the Regulated-Industry Buyer

Use these five questions in every eQMS evaluation. They test the capabilities that differentiate a regulated-industry eQMS from a general quality management platform delivered through a browser.

eLeaP’s eQMS demo covers all five questions live, in a cloud-hosted environment configured for the buyer’s regulatory framework and industry. The demo includes the training integration demonstration, the DHF record network view for medical device buyers, and the batch record execution workflow for pharmaceutical buyers. Request a scoped eQMS demo at eleapsoftware.com.

Related resources: